Company
Headquarters: Taipei, Taiwan
TW$176.5 Million
TWD as of March 1, 2023
US$5.7 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $461.52 B |
Vertex Pharmaceuticals Incorporated | $107.23 B |
Regeneron Pharmaceuticals, Inc. | $100.01 B |
CSL Limited | $94.74 B |
Marinomed Biotech AG | $73.23 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Chuang Yi Biotech Co., ltd. engages in the research, development, and marketing of medicines and health foods in Taiwan. The company offers products in the areas of gastrointestinal, metabolism, and regular health care, as well as allergy reducing products. Chuang Yi Biotech Co., ltd. Swas founded in 2011 and is based in Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Chuang Yi Biotech co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6566 wb_incandescent